An intraprostatic modified release formulation of antiandrogen 2-hydroxyflutamide for localized prostate cancer

TL Tammela, M Häggman, S Ladjevardi… - The Journal of …, 2017 - auajournals.org
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in NanoZolid®) in men …
被引用次数：9 相关文章
[PDF] helsinki.fi

[PDF][PDF] An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela - 2017 - researchportal.helsinki.fi
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in Nano-Zolid®) in men …

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela, M Häggman… - The Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose We investigated the tolerability, safety and antitumor effects of a novel intraprostatic
depot formulation of antiandrogen 2-hydroxyflutamide (in NanoZolid®) in men with localized …

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela, M Häggman, S Ladjevardi… - Journal of …, 2017 - journals.lww.com
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in NanoZolid®) in men …
[PDF] liddspharma.com

[PDF][PDF] An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela, M Häggman, S Ladjevardi, K Taari… - Group, 2017 - liddspharma.com
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in Nano-Zolid®) in men …

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela, M Häggman, S Ladjevardi, K Taari… - Journal of …, 2017 - diva-portal.org
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in Nano-Zolid (R)) in …

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.

TL Tammela, M Häggman, S Ladjevardi… - The Journal of …, 2017 - europepmc.org
Purpose We investigated the tolerability, safety and antitumor effects of a novel intraprostatic
depot formulation of antiandrogen 2-hydroxyflutamide (in NanoZolid®) in men with localized …
[PDF] helsinki.fi

[PDF][PDF] An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela - 2017 - helda.helsinki.fi
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in Nano-Zolid®) in men …
[PDF] researchgate.net

[PDF][PDF] An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

TL Tammela, M Häggman, S Ladjevardi, K Taari… - Group, 2017 - researchgate.net
Purpose: We investigated the tolerability, safety and antitumor effects of a novel
intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in Nano-Zolid®) in men …

[引用][C] An intraprostatic modified release formulation of antiandrogen 2-hydroxyflutamide for localized prostate cancer

T Tammela, M Häggman, S Ladjevardi… - Journal of …, 2017 - researchportal.tuni.fi
An intraprostatic modified release formulation of antiandrogen 2-hydroxyflutamide for localized
prostate cancer — Tampere University Research Portal Skip to main navigation Skip to search …